Open AccessPharmacokinetics of a Novel Zolpidem Nasal Spray for Rapid Management of Insomnia: First Trial in Humans
Author(s) -
Cheng-Tai Li,
TungPing Su,
Yanfeng Wang,
Benjamin Lee,
Melvin Toh,
Tony W. Ho
Publication year - 2016
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.6264
Subject(s) - zolpidem , medicine , pharmacokinetics , tolerability , placebo , cmax , nasal administration , adverse effect , anesthesia , nasal spray , bioavailability , pharmacology , insomnia , alternative medicine , pathology
The present single-dose, parallel-group, randomized, double-blind, placebo-controlled study is to evaluate the pharmacokinetics, tolerability and safety of zolpidem tartrate nasal spray (ZNS) as compared to placebo in healthy subjects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom